๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-08-25

Human Cerebrovascular Blood Flow and Sex Differences in Metabolic Syndrome (NCT07218653)

๐ŸŸก Not Yet Recruiting Early Phase1 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: University of Wisconsin, Madison

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

This study tests the hypothesis that Metabolic Syndrome (MetSyn) decreases cerebral blood flow (CBF) more in females than males due in part to the sex-specific loss of COX vasodilation. Male and female participants will be enrolled in two groups: Healthy Controls versus participants with MetSyn.

Who can join: Review the eligibility criteria below.

Location: University of Wisconsin โ€” Madison, Wisconsin

Age range: 18 Years to 45 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • University of Wisconsin โ€” Madison, Wisconsin

๐Ÿ“ž Contact the Study Coordinator

Phone: (608) 263-6308

Email: sbolin@wisc.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—